Test Price
3,000 AED✅ Home Collection Available
Expert Panel 4: Multi‑Specialist Oncopathology Second‑Opinion Review in UAE
Executive Summary & Core Metrics
The Expert Panel 4 (Oncopathology Second-Opinion Review) provides an advanced, multi-disciplinary consensus evaluation of existing histopathology slides, paraffin-embedded tissue blocks, and cytology smears. This rigorous review, conducted by a specialized team including oncopathologists, surgical pathologists, and bio-repository managers, delivers 99.9% diagnostic concordance and critical validation for complex oncology cases. Our streamlined process ensures secure archival tissue specimen retrieval, ISO-certified quality management, and comprehensive post-report telephonic guidance by a Specialist Diagnostic Radiologist.
- Accuracy Guarantee: 99.9% Diagnostic Concordance via ISO-accredited multi-expert consensus review.
- Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval from any hospital or clinic in the UAE.
- Clinical Guidance: Dedicated telephonic consultation to explain panel findings and therapeutic implications.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Expert Panel 4 in Oncopathology
This service involves the independent review of submitted pathological material by a minimum of four specialist physicians, followed by a structured consensus conference to establish a unified diagnostic report. The process adheres to international standards for cancer diagnosis and classification, providing a definitive second opinion that minimizes interpretive variability and ensures the highest level of diagnostic accuracy for treatment-critical decisions.
| Feature | Expert Panel 4 (Our Test) | Standard Single‑Pathologist Review |
|---|---|---|
| Methodology | Multi-specialist light microscopy & consensus reporting | Single pathologist microscopic examination |
| Diagnostic Precision | 99.9% sensitivity, panel agreement | ~90‑95% sensitivity, individual variability |
| Turnaround Time | 7 days | 10‑14 days |
| Price (AED) | 3,000 AED | 1,500‑2,000 AED |
Physician Insight & Safety Protocols
“As a Specialist Diagnostic Radiology consultant, I emphasize that the Expert Panel 4 review provides a critical safety net in oncological diagnosis. This multi-layered consensus minimizes interpretive variability and ensures that your treatment plan is based on the most accurate pathological assessment available. Please view this as a complementary layer of precision medicine, interpreted in conjunction with your full clinical history and imaging findings.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
⛔ Medication & Clinical Advisory
Do not discontinue, alter, or initiate any prescribed medication or therapy based solely on this panel review. The findings are advisory and intended to support, not replace, the direct clinical management and emergency care provided by your treating physician.
🚨 Exclusion Criteria & Emergency Red Flags
- This review is strictly for previously obtained and reported histopathology or cytology material. It is not a primary diagnostic service for new, undiagnosed lesions.
- Not suitable for patients presenting with acute, rapidly progressive symptoms, severe pain, uncontrolled bleeding, or suspected oncological emergencies.
- If you experience a medical emergency, immediately contact your nearest emergency department. Do not delay urgent care while awaiting panel results.
- All consensus interpretations are advisory; final treatment decisions rest solely with your primary healthcare provider.
Patient FAQ & Clinical Guidance
1. What is the Expert Panel 4 Oncopathology Review and why is it recommended?
The Expert Panel 4 is a multi-specialist consensus review of your existing cancer biopsy slides (histopathology or cytology). It is recommended to confirm a challenging diagnosis, resolve discrepancies between previous reports, and provide a highly authoritative second opinion to guide critical treatment decisions, such as chemotherapy or surgical planning.
2. How do I submit my pathology slides and blocks for review?
DNA Labs UAE coordinates a secure, temperature-controlled medical courier retrieval of your archival solid tissue specimens (paraffin blocks, stained/unstained slides) directly from your hospital or clinic. Our logistics team ensures a complete chain of custody and safe transfer to our Dubai Healthcare City facility.
3. When will I receive the results and who will explain them to me?
Your comprehensive consensus report will be issued within 7 business days of sample receipt. Following delivery, a telephonic consultation is scheduled with a specialist physician to explain the panel's findings, diagnostic rationale, and clinical implications in detail.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
- Operated under the UAE’s Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient safety and clinical consent protocols adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified Quality Management System (Cert: INT/EGQ/2509DA/3139).
- All pathological material is handled with the highest level of confidentiality and integrity under DHA regulatory oversight.
Clinical & Logistical Metadata
| Test Name | Expert Panel 4 (Multi-Specialist Oncopathology Second-Opinion Review) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 7 Business Days |
| Sample Type / Matrix | Archival Solid Tissue Specimen (FFPE Tissue Blocks, Histopathology Slides, Cytology Smears). Hospital Extraction Only – Sample collection is conducted strictly via secure medical courier retrieval from an accredited medical facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Multi-Specialist Light Microscopy & Structured Consensus Reporting (ISO 9001:2015) |
| ICD-10-CM Code | C80.1 (Malignant neoplasm, unspecified), Z85.00 (Personal history of malignant neoplasm), Z15.09 (Genetic susceptibility to other malignant neoplasm) |
| LOINC Code | 67729-2 (Pathology consultation note) |
| DHA Facility License & Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians